Biotech Derivatives Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: limit who wrote (7)	2/25/1999 10:19:00 AM
From: LLCF	Read Replies (1) of 555

Icos options are fair value according to my historical info... this does NOT take into account any news that may come out however! So as per the "Mast" at the beginning of the thread they may still be mispriced on the cheap side if you expect any announcements. You will have to do homework on expected announcements and sell an option accordingly... I will say that many biotech options are often "high" by historical standards and if you don't expect much to happen for a period of time you may want to sell some calls... this is NOT the case with ICOS.. these look "fair value" to me. These are the types I would consider buying if I thought some announcement related movement might happen. DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next